Predicting the risk of mortality in children with dengue-induced hepatitis admitted to the paediatric intensive care unit

Table 1 Baseline clinical and laboratory characteristics of study participants on pediatric intensive care unit admission and associated outcomes at discharge (n = 459), n (%)

Characteristics	No. participants	Statistics
Age (years)	457	7.7 (4.3-10.1)
Female patients	459	193 (42)
Underlying diseases	459	38 (8.3)
Day of occurrence of dengue shock since onset of fever (days)	451	5 (4-5)
Grading of DSS	459
Compensated DSS		402 (87.6)
Decompensated DSS		57 (12.4)
Severe bleeding	456	76 (16.7)
Respiratory rate (breaths/minute)	405	26 (24-30)
Systolic shock index (bpm/mmHg)	390	1.33 (1.15-1.6)
Diastolic shock index (bpm/mmHg)	390	1.83 (1.5-2.25)
Vasoactive-inotropic score > 30	459	45 (9.8)
White blood cell count, (× 109/L)	456	5.35 (3.76-7.8)
Peak hematocrit	446	47 (44-51)
Nadir hematocrit	446	38 (33-41)
Platelet cell count, (× 109/L)	457	32.6 (20-48)
Aspartate aminotransferase (IU/L)	459	751 (465-1416)
Alanine aminotransferase (IU/L)	459	344 (221-638)
International normalized ratio	406	1.40 (1.18-1.96)
Prothrombin time (second)	404	18 (15-27)
Activated partial thromboplastin time (second)	405	52 (43-69)
Peak serum bilirubin level (mg/dL)	119	1.9 (1.04-5.3)
Peak serum ammonia level (µmol/L)	64	117 (80-197)
Blood creatinine (µmol/L)	447	54 (44-63)
Troponin I (ng/mL)	164	0.036 (0.01-0.22)
Blood lactate (mmol/L)	293	2.9 (2.0-4.5)
Length of pediatric intensive care unit stay (days)	459	3 (2-5)
Length of hospital stay (days)	459	5 (4-10)
Fatal outcome	459	42 (9.2)

Summary statistics are presented as median (interquartile range) for continuous variables and frequency (%) for categorical variables. DSS: Dengue shock syndrome.